Risk factors for the development of chronic kidney disease among Nigerians with essential hypertension

Journal of Medical Sciences

Volumn 7, Issue 4, 2007, Pages 579-584

  Nwankwo, Emeka A ^a   Wudiri, William W ^a   Akinsola, Adewale ^b  

^a UNIVERSITY OF MAIDUGURI   (Nigeria)

^b Department of Community Medicine   (Nigeria)

Author keywords

CKD; Hypertension; Progression; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE DURATION; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION RETINOPATHY; HYPERURICEMIA; KIDNEY INJURY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NIGERIA; PATIENT COMPLIANCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 34250827810     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.579.584     Document Type: Article

References (23)

1. Bakris, G.L., A. Mangrum, J.B. Copley, N. Vicknair and R. Sadler, 1997. Calcium channel blockers or Beta blockade on the progression of Diabetic renal disease in African Americans. Hypertension, 29: 744-750.
2. Bigazzi, R., S. Bianchi and D. Baldari et al., 1994. Microalbuminuria and salt sensitivity. Hypertension, 23: 195-299.
3. Bloem, L.J., A.K. Manatunga, D.A. Tewksbury and J.H. Prat, 1995. The serum angiotensinogen and variants of the angiotensinogen gene in white and black children. J. Clin. Invest., 95: 948-953.
4. Coresh, J., B.C. Astor, T. Greene, G. Eknoyan and A.S. Levey, 2003. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Survey. Am. J. Kidney Dis., 41: 1-12.
5. Domrongkichaiporn, S., P. Sritara, C. Kitiyakara, W. Stitchantrakul, V. Krittaphol, P. Lolechka, S. Cheepudomwit and T. Yipintsoi, 2005. Risk factors for the development of decreased kidney function in a southeast Asian population: A 12-year cohort study. J. Am. Soc. Nephrol., 16: 791-799.
6. Fergusson, R., C.E. Grim and T.J. Opgenorth, 1988. A familial risk of chronic renal failure among blacks on dialysis. J. Clin. Epidemiol., 41: 1189-1196.
7. Fernadez-Llama, P., E. Poch and J. Oroila et al., 1998. Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Intl., 53: 1743-1747.
8. Fox, C.S., M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson and D. Levy, 2004. Predictors of new-onset kidney disease in a community- based population. JAMA., 291: 1882-1888.
9. Freedman, B.I., B.J. Spray, A.B. Tuttle and V.M. Buckalew, 1993. The familial risk of end stage renal disease in African Americans. Am. J. Kidney Dis., 21: 387-393.
10. Johnson, R.J., M.S. Segal, T. Srinvas, A. Ejaz, W. Mu, C. Roncal, G. Sanshez-Lozada, M. Gersch, B. Rodriguez-Iturbe, D. Kang and J.H. Acosta, 2005. Essential Hypertension, Progressive Renal Disease and Uric Acid: A pathogenetic link? J. Am. Soc. Nephrol., 16: 1909-1919.
11. King, H., R.E. Auburt and W.H. Herman, 1998. Global burden of diabetes 1995-2025: Prevalence, numerical, estimates and projections. Diabetes Care, 21: 1414-1431.
12. Klag, M.J., P.K. Whelton and B.C. Randal, 1993. Blood pressure and end stage renal disease in men. N. Eng. J. Med., 329: 1456-1462.
13. Lysaght, M.J., 2002. Maintenance dialysis population dynamics: Current trends and long term implications. J. Am. Soc. Nephrol., 13: 37-40.
14. Mann, J.F., H.C. Gerstein, J. Pogue, J. Bosch and S. Yusuf, 2001. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril. The HOPE randomised trial. Ann. Intl. Med., 134: 629-636.
15. Marcantoni, C., L. Ma, C. Federspiel and A.B. Fogo, 2002. Hypertensive nephrosclerosis in African American versus Caucasians. Kidney Intl., 62: 172-180.
16. Ojo, O.S., A.A. Akinsola, S.O. Nwosu and W.O. Odesanmi, 1992. Pathological basis of chronic renal failure in Nigerians. An autopsy study. Trop. Geogr. Med., 44: 42-46.
17. Orth, S.R. and E. Ritz, 2002. The renal risks of smoking: An update. Curr. Opin. Nephrol. Hypertens., 11: 483-488.
18. Pugley, D., 2005. Racial and ethnic disparities in renal disease: Kidney Intl., 68: 1364-1365.
19. Toto, R.D., H.C. Mitchel, R.D. Smith, H.L. Lee, D. McIntire and W.A. Pettinger, 1995. Strict blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Intl., 48: 851-859.
20. United States Renal Data System. USRDS, 2001. Annual Data Report: Atlas of End Stage Renal Disease in the US, Bethseda MD. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
21. Valderrabano, F., F. Gomez Campdera and E.H. Jones, 1998. Hypertension as a cause of end stage renal disease: Lessons from international registries. Kidney Intl., 54 (Suppl 68) S60-66.
22. Xue, J.L., J.Z. Ma, T.A. Louis and A.J. Collins, 2001. Forecast of the number of patient with end stage renal disease in the United States to the year 2010. J. Am. Soc. Nephrol., 12: 2753-2758.
23. Zeeuw, D.D., H.L. Hillege and P.E. de Jong, 2005. The kidney a cardiovascular risk marker and a new target for therapy. Kidney Intl. suppl., 98: s25-s29.